Mehra and Subramanian discussed preclinical safety studies with the gene therapy SLS-004 and plans for future research.
Krishna Subramanian, PhD
Advertisement
Articles by Krishna Subramanian, PhD
Mehra and Subramanian discussed preclinical research with the investigational gene therapy SLS-004.
Advertisement
Latest Updated Articles
Raj Mehra, PhD, and Krishna Subramanian, PhD, on Striving For Disease-Modifying Therapies in Parkinson DiseasePublished: February 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
2
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
5